Search research articles
Contact Us
Filters
Showing results (91-100 of 129) with videos related to
Page
of 13
Sort By:
The Journal of Biological Chemistry
|
July 8, 2016
A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias
Daniele Bolognini, Daryl Hodge, Karolina Nilsson, et al.
Biomedical Optics Express
|
April 13, 2026
Wide-field and non-invasive imaging of brain tumours with scattered light techniques
Philip Binner, Jack Radford, Ilya Starshynov, et al.
Biomedical Optics Express
|
May 11, 2026
Erratum: Wide-field and non-invasive imaging of brain tumours with scattered light techniques: erratum
Philip Binner, Jack Radford, Ilya Starshynov, et al.
Chemmedchem
|
August 28, 2020
Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M<sub>1</sub> Muscarinic Acetylcholine Receptor
Manuela Jörg, Elham Khajehali, Emma T van der Westhuizen, et al.
Journal of Medicinal Chemistry
|
March 7, 2020
Structure-Activity Relationship Studies of Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators
Elisabeth Rexen Ulven, Tezz Quon, Eugenia Sergeev, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 25, 2015
CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo
Mario Rossi, Inigo Ruiz de Azua, Luiz F Barella, et al.
European Journal of Medicinal Chemistry
|
July 9, 2023
Design, synthesis and evaluation of novel 2-phenyl-3-(1H-pyrazol-4-yl)pyridine positive allosteric modulators for the M<sub>4</sub> mAChR
Manuela Jörg, Emma T van der Westhuizen, Yao Lu, et al.
Science Signaling
|
November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease
Louis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
ACS Chemical Neuroscience
|
December 15, 2018
6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M<sub>1</sub> mAChR: The Determinants of Allosteric Activity
Manuela Jörg, Emma T van der Westhuizen, Elham Khajehali, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 11, 2021
Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease
Miriam Scarpa, Colin Molloy, Laura Jenkins, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 129) with videos related to
Sort By:
Page
of 13
The Journal of Biological Chemistry
|
July 8, 2016
A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias
Daniele Bolognini, Daryl Hodge, Karolina Nilsson, et al.
Biomedical Optics Express
|
April 13, 2026
Wide-field and non-invasive imaging of brain tumours with scattered light techniques
Philip Binner, Jack Radford, Ilya Starshynov, et al.
Biomedical Optics Express
|
May 11, 2026
Erratum: Wide-field and non-invasive imaging of brain tumours with scattered light techniques: erratum
Philip Binner, Jack Radford, Ilya Starshynov, et al.
Chemmedchem
|
August 28, 2020
Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M<sub>1</sub> Muscarinic Acetylcholine Receptor
Manuela Jörg, Elham Khajehali, Emma T van der Westhuizen, et al.
Journal of Medicinal Chemistry
|
March 7, 2020
Structure-Activity Relationship Studies of Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators
Elisabeth Rexen Ulven, Tezz Quon, Eugenia Sergeev, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 25, 2015
CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo
Mario Rossi, Inigo Ruiz de Azua, Luiz F Barella, et al.
European Journal of Medicinal Chemistry
|
July 9, 2023
Design, synthesis and evaluation of novel 2-phenyl-3-(1H-pyrazol-4-yl)pyridine positive allosteric modulators for the M<sub>4</sub> mAChR
Manuela Jörg, Emma T van der Westhuizen, Yao Lu, et al.
Science Signaling
|
November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease
Louis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
ACS Chemical Neuroscience
|
December 15, 2018
6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M<sub>1</sub> mAChR: The Determinants of Allosteric Activity
Manuela Jörg, Emma T van der Westhuizen, Elham Khajehali, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 11, 2021
Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease
Miriam Scarpa, Colin Molloy, Laura Jenkins, et al.
Page
of 13